EICHOR
● Completed
Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction
Condition: Ocular Hypertension · Open Angle Glaucoma · Sponsor: Alcon Research
About this study
This study is designed to see how safe and effective a new eye drop, called Reformulated PG324, is for lowering eye pressure in people with open-angle glaucoma (OAG) or ocular hypertension (OHT).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (30)
| Trinity Research Group | Dothan, Alabama, United States | — |
| Eye Doctors of Arizona | Phoenix, Arizona, United States | — |
| Orange County Ophthalmology Medical Group | Garden Grove, California, United States | — |
| United Medical Research Institute | Inglewood, California, United States | — |
| Eye Research Foundation | Newport Beach, California, United States | — |
| North Bay Eye Associates | Petaluma, California, United States | — |
| Sacramento Eye Consultants | Sacramento, California, United States | — |
| Central Florida Eye Specialists | DeLand, Florida, United States | — |
| Glaucoma Specialists of South Florida | Delray Beach, Florida, United States | — |
| East Coast Institute for Research, LLC | Jacksonville, Florida, United States | — |
| Central Florida Eye Associates | Lakeland, Florida, United States | — |
| The Eye Institute of West Florida | Largo, Florida, United States | — |
+ 18 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07082816